Amgen Inc.

Pharmaceuticals
United States
Executive 1Mr. Robert A. Bradway, Chairman; President; Chief Executive Officer | Chairman; President; Chief Executive Officer
Executive 2Mr. Anthony C. Hooper, Executive Vice President; | Executive Vice President;
Earnings Per Share Growth (%)0.90%
Cost of Goods Sold (US$ Millions)$4,422
Current Liabilities (US$ Millions)$7,008
Total Assets (US$ Millions)$34,713
Long Term Debt (Millions)$30,215
Return on Equity23.34%
Revenue (US$ Millions)$20,063
Total Company Assets$69,009
Revenue Growth (%)7.43%
Net Income (US$ Millions)$5,158
Earnings Per Share (US$)$6.70
Total Equity (US$ Millions)$25,778
Profit Margin (%)25.71%
Debt To Equity Ratio (%)1.17%
Inventories (Millions)$2,647